tradingkey.logo


tradingkey.logo


Neuropace Inc

NPCE
13.330USD
-0.330-2.42%
終倀 03/27, 16:00ET15分遅れの株䟡
308.49M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Neuropace Inc 䌁業名

NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. The RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorders.

Neuropace Incの䌁業情報


䌁業コヌドNPCE
䌚瀟名Neuropace Inc
䞊堎日Apr 22, 2021
最高経営責任者「CEO」Becker (Joel D)
埓業員数184
蚌刞皮類Ordinary Share
決算期末Apr 22
本瀟所圚地455 N. Bernardo Avenue
郜垂MOUNTAIN VIEW
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号94043
電話番号16502372700
りェブサむトhttps://www.neuropace.com/
䌁業コヌドNPCE
䞊堎日Apr 22, 2021
最高経営責任者「CEO」Becker (Joel D)

Neuropace Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
595.18K
+0.31%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
--
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
40.03K
+2.16%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
33.45K
-8.02%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
19.16K
+6.02%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
14.86K
+6.14%
Ms. Renee Ryan
Ms. Renee Ryan
Independent Director
Independent Director
--
--
Ms. Lisa Andrade
Ms. Lisa Andrade
Independent Director
Independent Director
--
--
Mr. Joel D. Becker
Mr. Joel D. Becker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
595.18K
+0.31%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
--
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
40.03K
+2.16%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
33.45K
-8.02%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
19.16K
+6.02%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
14.86K
+6.14%

収益内蚳

FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q1
FY2023
FY2022
FY2021
FY2020
FY2019
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
United States
27.35M
0.00%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Thu, Feb 19
曎新時刻: Thu, Feb 19
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Accelmed Growth Partners Management Ltd
13.17%
Polar Capital LLP
8.55%
Soleus Capital Management, L.P.
8.03%
Morgan Stanley & Co. LLC
7.55%
OrbiMed Advisors, LLC
7.15%
他の
55.55%
株䞻統蚈
株䞻統蚈
比率
Accelmed Growth Partners Management Ltd
13.17%
Polar Capital LLP
8.55%
Soleus Capital Management, L.P.
8.03%
Morgan Stanley & Co. LLC
7.55%
OrbiMed Advisors, LLC
7.15%
他の
55.55%
皮類
株䞻統蚈
比率
Investment Advisor/Hedge Fund
26.53%
Private Equity
20.31%
Investment Advisor
19.42%
Hedge Fund
18.87%
Research Firm
9.12%
Individual Investor
2.59%
Pension Fund
0.51%
Bank and Trust
0.12%
Venture Capital
0.10%
他の
2.44%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
209
30.63M
92.59%
-6.41M
2025Q3
198
31.14M
94.13%
-2.95M
2025Q2
184
29.13M
88.81%
-1.17M
2025Q1
183
29.76M
92.98%
+2.27M
2024Q4
144
26.53M
86.07%
-49.99K
2024Q3
134
26.01M
86.62%
-1.02M
2024Q2
129
25.88M
90.53%
+502.69K
2024Q1
131
24.82M
87.55%
-513.24K
2023Q4
113
24.06M
92.70%
-1.70M
2023Q3
103
24.86M
97.20%
-1.10M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Accelmed Growth Partners Management Ltd
4.43M
13.4%
--
--
Apr 09, 2025
Polar Capital LLP
3.10M
9.36%
--
--
Sep 30, 2025
Soleus Capital Management, L.P.
2.96M
8.94%
+645.00K
+27.89%
Sep 30, 2025
Morgan Stanley & Co. LLC
2.54M
7.67%
-38.81K
-1.51%
Sep 30, 2025
OrbiMed Advisors, LLC
2.61M
7.9%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.64M
4.95%
+103.79K
+6.76%
Sep 30, 2025
Driehaus Capital Management, LLC
939.52K
2.84%
-65.84K
-6.55%
Sep 30, 2025
The Vanguard Group, Inc.
1.44M
4.34%
+66.57K
+4.86%
Sep 30, 2025
First Light Asset Management, LLC
1.36M
4.11%
-20.34K
-1.47%
Sep 30, 2025
Kent Lake PR LLC
1.00M
3.02%
+75.00K
+8.11%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
iShares Neuroscience and Healthcare ETF
0.64%
Principal U.S. Small-Cap ETF
0.05%
iShares Micro-Cap ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Proshares Ultra Russell 2000
0.01%
詳现を芋る
iShares Neuroscience and Healthcare ETF
比率0.64%
Principal U.S. Small-Cap ETF
比率0.05%
iShares Micro-Cap ETF
比率0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.02%
ProShares Hedge Replication ETF
比率0.02%
ProShares UltraPro Russell2000
比率0.01%
iShares Russell 2000 ETF
比率0.01%
iShares Russell 2000 Growth ETF
比率0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
比率0.01%
Proshares Ultra Russell 2000
比率0.01%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™